Kamalaya Company Announced that Will release its vaccine Sputnik v Nasal spray in the first three months of 2022. In the middle of this year, Russian researchers a Clinical examination of the drug in children 8 to 12 years.
“Sputnik nasal vaccine Especially the highly contagious variant is effective against Omicron, Not only from the point of view of protection against the virus itself, but Also, prevent its spreadKamaleya said via Twitter.
On November 27, Denise Lokunov, deputy director of Kamaleya, described the spray vaccine as “comfortable, painless, and completely with minimal side effects.” The intraocular form was developed to “stimulate the immune system”, Which “refers to our immune system located in the nose and larynx.”
At the time, the director of the company, Alexander Kindsburg, said that people who were vaccinated against the corona virus were more likely to develop immunity regardless of the vaccines they had previously received.
President of Russia, Vladimir Putin, Who participated in the experiments on the Nazi product in November, Highlighted This Tuesday The Sputnik V vaccine is most effective against the Omicron variant He said that “90% security guarantee”, Sputnik news agency reported.
So far, Sputnik V has been approved for use in more than 70 countries and 21 other states have approved the single-dose Sputnik Lite vaccine.